These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9109860)

  • 21. A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis.
    van der Lubbe PA; Dijkmans BA; Markusse HM; Nässander U; Breedveld FC
    Arthritis Rheum; 1995 Aug; 38(8):1097-106. PubMed ID: 7639806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon gamma, IL2, IL4, IL10 and TNFalpha secretions in multiple sclerosis patients treated with an anti-CD4 monoclonal antibody.
    Lopez E; Racadot E; Bataillard M; Berger E; Rumbach L
    Autoimmunity; 1999; 29(2):87-92. PubMed ID: 10433069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.
    Lorenz HM; Antoni C; Valerius T; Repp R; Grünke M; Schwerdtner N; Nüsslein H; Woody J; Kalden JR; Manger B
    J Immunol; 1996 Feb; 156(4):1646-53. PubMed ID: 8568271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Open therapeutic trial of anti-T CD4 monoclonal antibody in multiple sclerosis].
    Rumbach L; Racadot E; Bataillard M; Galmiche J; Henlin JL; Trutmann M; Ziegler F; Wijdenes J
    Rev Neurol (Paris); 1994; 150(6-7):418-24. PubMed ID: 7747009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens.
    Choy EH; Pitzalis C; Cauli A; Bijl JA; Schantz A; Woody J; Kingsley GH; Panayi GS
    Arthritis Rheum; 1996 Jan; 39(1):52-6. PubMed ID: 8546738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.
    Horneff G; Sack U; Kalden JR; Emmrich F; Burmester GR
    Clin Exp Immunol; 1993 Feb; 91(2):207-13. PubMed ID: 7679058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes.
    Choy EH; Adjaye J; Forrest L; Kingsley GH; Panayi GS
    Eur J Immunol; 1993 Oct; 23(10):2676-81. PubMed ID: 8104799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.
    van Oosten BW; Barkhof F; Scholten PE; von Blomberg BM; Adèr HJ; Polman CH
    Arch Neurol; 1998 Jun; 55(6):793-8. PubMed ID: 9626770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of isotype and Fc region on in vitro function of a mouse/human chimeric CD4 antibody.
    Dalesandro MR; Pak KY; Tam S; Wilson E; Looney JE; Knight DM; Ghrayeb J; Reiter C; Rieber EP; Riethmuller G
    Int Immunol; 1993 Mar; 5(3):283-91. PubMed ID: 8466865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis.
    Bongioanni MR; Durelli L; Ferrero B; Imperiale D; Oggero A; Verdun E; Aimo G; Pagni R; Geuna M; Bergamasco B
    J Neurol Sci; 1996 Nov; 143(1-2):91-9. PubMed ID: 8981304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis.
    Fellay B; Chofflon M; Juillard C; Paunier AM; Landis T; Roth S; Gougeon ML
    Immunology; 2001 Dec; 104(4):383-91. PubMed ID: 11899423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10.
    Gbadamosi J; Buhmann C; Tessmer W; Moench A; Haag F; Heesen C
    Eur Neurol; 2003; 49(3):137-41. PubMed ID: 12646755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial.
    Choy EH; Panayi GS; Emery P; Madden S; Breedveld FC; Kraan MC; Kalden JR; Rascu A; Brown JC; Rapson N; Johnston JM
    Rheumatology (Oxford); 2002 Oct; 41(10):1142-8. PubMed ID: 12364634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts.
    Moreland LW; Pratt PW; Bucy RP; Jackson BS; Feldman JW; Koopman WJ
    Arthritis Rheum; 1994 Jun; 37(6):834-8. PubMed ID: 7911664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients.
    Racadot E; Rumbach L; Bataillard M; Galmiche J; Henlin JL; Truttmann M; Herve P; Wijdenes J
    J Autoimmun; 1993 Dec; 6(6):771-86. PubMed ID: 8155256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
    Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
    Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.
    Horneff G; Burmester GR; Emmrich F; Kalden JR
    Arthritis Rheum; 1991 Feb; 34(2):129-40. PubMed ID: 1994909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenetic cytokine restriction in multiple sclerosis].
    Odinak MM; Bisaga GN; kalinina NM; Akimov SB; Davydova NI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(9):39-44. PubMed ID: 11586702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.